[1]
|
B. Coburn, A. M. Morris, G. Tomlinson and A. S. Detsky, “Does This Adult with Suspected Bacte Remia Require Blood Cultures?” JAMA, Vol. 308, No. 5, 2012, pp. 502-511. doi:10.1001/jama.2012.8262
|
[2]
|
N. I. Shapiro, R. E. Wolfe, S. B. Wright, R. Moore and D. W. Bates, “Who Needs a Blood Culture? A Prospectively Derived and Validated Prediction Rule,” Journal of Emergency Medicine, Vol. 35, No. 3, 2008, pp. 255-264.
doi:10.1016/j.jemermed.2008.04.001
|
[3]
|
C. C. Lee, C. J. Wu, C. H. Chi, N. Y. Lee, P. L. Chen, H. C. Lee, C. M. Chang, N. Y. Ko and W. C. Ko, “Prediction of Community-Onset Bacte Remia among Febrile Adults Visiting an Emergency Department: Rigor Matters,” Diagnostic Microbiology and Infectious Diseases, Vol. 73, No. 2, 2012, pp. 168-173.
doi:10.1016/j.diagmicrobio.2012.02.009
|
[4]
|
M. P. Weinstein, “Blood Culture Contamination: Persisting Problems and Partial Progress,” Journal of Clinical Microbiology, Vol. 41, No. 6, 2003, pp. 2275-2278.
doi:10.1128/JCM.41.6.2275-2278.2003
|
[5]
|
R. B. Schifman, C. L. Strand, F. A. Meier and P. J. Howanitz, “Blood Culture Contamination: A College of American Pathologists Q-Probes Study Involving 640 Institutions and 497134 Specimens from Adult Patients,” Archives of Pathology and Laboratory Medicine, Vol. 122, No. 3, 1998, pp. 216-221.
|
[6]
|
M. L. Towns, W. R. Jarvis and P. R. Hsueh, “Guidelines on Blood Cultures,” Journal of Microbiology Immunology and Infection, Vol. 43, No. 4, 2010, pp. 347-349.
doi:10.1016/S1684-1182(10)60054-0
|
[7]
|
K. K. Hall and J. A. Lyman, “Updated Review of Blood Culture Contamination,” Clinical Microbiology Reviews, Vol. 19, No. 4, 2006, pp. 788-802.
doi:10.1128/CMR.00062-05
|
[8]
|
C. J. Grace, J. Lieberman, K. Pierce and B. Littenberg, “Usefulness of Blood Culture for Hospitalized Patients Who Are Receiving Antibiotic Therapy,” Clinical Infectious Diseases, Vol. 32, No. 11, 2001, pp. 1651-1655.
doi:10.1086/320527
|
[9]
|
C. W. Stratton, “The Use and Abuse of Blood Cultures,” Infectious Disease Newsletter, Vol. 10, No. 4, 1991, pp. 28-31.
|
[10]
|
Y. F. Van der Heijden, G. Miller, P. W. Wright, B. E. Shepherd, T. L. Daniels and T. R. Talbot, “Clinical Impact of Blood Cultures Contaminated With Coagulase-Negative Staphylococci at an Academic Center,” Infection Control Hospital Epidemiology, Vol. 32, No. 6, 2011, pp. 623-625. doi:10.1086/660096
|
[11]
|
J. M. Darby, P. Linden, W. Pasculle and M. Saul, “Utilization and Diagnostic Yield of Blood Cultures in a Surgical Intensive Care Unit,” Critical Care Medicine, Vol. 25, No. 6, 1997, pp. 989-994.
doi:10.1097/00003246-199706000-00016
|
[12]
|
B. P. Ehrenstein, T. Jarry, H. J. Linde, J. Scholmerich and T. Gluck, “Low Rate of Clinical Consequences Derived from Results of Blood Cultures Obtained in an Internal Medicine Emergency Department,” Infection, Vol. 33, No. 5-6, 2005, pp. 314-319. doi:10.1007/s15010-005-5065-5
|
[13]
|
B. P. Ehrenstein, V. Ehrenstein, C. Henke, H. J. Linde, B. Salzberger, J. Scholmerich and T. Glück, “Risk Factors for Negative Blood Cultures in Adult Medical Inpatients—A Retro Spective Analysis,” BMC Infectious Diseases, Vol. 8, 2008, pp. 148-152.
doi:10.1186/1471-2334-8-148
|
[14]
|
M. Aronson and D. Bor, “Blood Cultures,” Annals of Internal Medicine, Vol. 106, No. 2, 1987, pp. 246-253.
doi:10.7326/0003-4819-106-2-246
|
[15]
|
N. Bartlett and M. Naughton, “Assessing the Utility of Repeat Blood Cultures Obtained during Neutropenic Fever,” American Society of Clinical Oncology Annual Meeting, 1999, Abstract No. 2269.
|
[16]
|
M. S. Tabriz, K. Riederer, J. Baran and R. Khatib, “Repeating Blood Cultures during Hospital Stay: Practice Pattern at a Teaching Hospital and a Proposal for Guidelines,” Clinical Microbiology and Infection, Vol. 10, No. 7, 2004, pp. 624-627.
doi:10.1111/j.1469-0691.2004.00893.x
|
[17]
|
F. J. Roberts, “The Value of the Second Blood Culture,” Journal of Infectious Diseases, Vol. 168, No. 3, 1993, pp. 795-796. doi:10.1093/infdis/168.3.795
|
[18]
|
S. Shafazand and A. B. Weinacker, “Blood Cultures in the Critical Care Unit: Improving Utilization and Yield,” Chest, Vol. 122, No. 5, 2002, pp. 1727-1736.
doi:10.1378/chest.122.5.1727
|
[19]
|
P. H. Chandrasekar and W. J. Brown, “Clinical Issues of Blood Cultures,” Archives of Internal Medicine, Vol. 154, No. 8, 1994, pp. 841-849.
doi:10.1001/archinte.1994.00420080023003
|
[20]
|
J. M. Mylotte and A. Tayara, “Blood Cultures: Clinical Aspects and Controversies,” European Journal of Clinical Microbiology and Infectious Disease, Vol. 19, No. 3, 2000, pp. 157-163. doi:10.1007/s100960050453
|
[21]
|
F. Y. Chang, B. B. MacDonald, J. E. Peacock Jr., D. M. Musher, P. Triplett, J. M. Mylotte, A. O’Donnell, M. M. Wagener and V. Yu, “A Prospective Multicenter Study of Staphylococcus Aureus Bacteremia: Incidence of Endocarditis, Risk Factors for Mortality, and Clinical Impact of Methicillin Resistance,” Medicine, Vol. 82, No. 5, 2003, pp. 322-332.
doi:10.1097/01.md.0000091185.93122.40
|
[22]
|
F. L. Weinbaum, S. Lavie, M. Danek, D. Sixsmith, G. F. Heinrich and S. S. Mills, “Doing It Right the First Time: Quality Improvement and the Contaminant Blood Culture,” Journal of Clinical Microbiology, Vol. 35, No. 3, 1997, pp. 563-565.
|
[23]
|
L. G. Bekeris, J. A. Tworek, M. K. Walsh and P. N. Valenstein, “Trends in Blood Culture Cotamination: A College of American Pathologists Q-Tracks Study of 356 Institutions,” Archives of Pathology and Laboratory Medicine, Vol. 129, No. 10, 2005, pp. 1222-1225.
|